Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Sylvie Jorieux0
Christine Gaucher0
Christophe De Romeuf0
Dominique Bourel0
Emmanuel Nony0
Nicolas Bihoreau0
Philippe Klein0
Date of Patent
May 11, 2010
Patent Application Number
10566358
Date Filed
July 30, 2004
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention concerns the use of human or humanized chimeric monoclonal antibodies which are produced in selected cell lines, said antibodies bringing about a high ADCC activity as well as a high secretion of cytokines and interleukins, for treating underpopulations of so-called weak-response patients exhibiting CD16 FCGR3A-158F homozygote or FCGR3A-158V/F heterozygote polymorphism.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.